QL
MLTX icon

Quarry LP’s MoonLake Immunotherapeutics MLTX Stock Holding History

Quarry LP’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$396K Buy
+21,250
New +$352K 0.07% 193
2025
Q4 		– Sell
-9,001
Closed -$64.5K – 2433
2025
Q3 		$64.5K Buy
9,001
+7,201
+400% +$375K 0.01% 710
2025
Q2 		$85K Sell
1,800
-600
-25% -$24.4K 0.02% 624
2025
Q1 		$93.8K Buy
+2,400
New +$103K 0.02% 544
2024
Q3 		– Sell
-3,000
Closed -$132K – 1901
2024
Q2 		$132K Buy
3,000
+1,900
+173% +$80.5K 0.04% 261
2024
Q1 		$55.3K Buy
1,100
+250
+29% +$13.6K 0.01% 418
2023
Q4 		$51.3K Buy
+850
New +$43.8K 0.01% 324

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return